��ҹ��1000��

Skip to content

��ҹ��1000��

New drug donanemab slows cognitive decline in early Alzheimer's

The experimental treatment donanemab is now the second antibody drug to slow cognitive decline in people with early stage Alzheimer’s disease, but questions remain about its real-world benefits and safety

News

Image of a nematode worm

Life

Nematode worms get the ‘munchies’ after having cannabis-like substance

News

��ҹ��1000��

Why expanding access to Narcan in the US won’t solve the opioid crisis

Analysis

��ҹ��1000��

Legal marijuana in the US may be less potent than packaging claims

News

��ҹ��1000��

Drug overdose deaths have quadrupled among older US adults

News

Wearable anti-anxiety device strokes your arm with a furry pompom

Technology

Wearable anti-anxiety device strokes your arm with a furry pompom

News

��ҹ��1000��

Caffeine linked to lower BMI and reduced risk of type 2 diabetes

News

SARS-CoV-2 could evolve into new variants that may evade existing vaccines

��ҹ��1000��

Inhaled powder that coats airways can block coronavirus infection

News

A laptop sits on a desk, opened to the homepage for the search engine Google. A person's hands enter from the left, with one hand's fingers placed on the laptop's keyboard.

Technology

Google's AI is best yet at answering medical and health questions

News

MRI scan of a brain

��ҹ��1000��

Sneaking drugs into the brain could treat conditions like Alzheimer's

A method of drug delivery that uses one of the body’s own systems to sneak mRNA molecules past the blood-brain barrier could help treat conditions such as Parkinson's, Alzheimer's and cancer

News

Technology

Robot guides needle into lungs more accurately than human doctors

News

��ҹ��1000��

Drug that targets ACE2 receptors may work against new covid variants

News

��ҹ��1000��

Alzheimer's drug lecanemab slows cognitive decline but concerns linger

News

Chemistry

Genetically modified tobacco plant produces cocaine in its leaves

News